RUA Life Sciences (RUA) Competitors GBX 10.52 -0.48 (-4.36%) (As of 12/20/2024 12:06 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors RUA vs. BELL, POLX, IHC, AVO, MHC, SUN, DEMG, SN, MXCT, and NIOXShould you be buying RUA Life Sciences stock or one of its competitors? The main competitors of RUA Life Sciences include Belluscura (BELL), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), MyHealthChecked (MHC), Surgical Innovations Group (SUN), Deltex Medical Group (DEMG), Smith & Nephew (SN), MaxCyte (MXCT), and NIOX Group (NIOX). These companies are all part of the "medical devices" industry. RUA Life Sciences vs. Belluscura Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy MyHealthChecked Surgical Innovations Group Deltex Medical Group Smith & Nephew MaxCyte NIOX Group RUA Life Sciences (LON:RUA) and Belluscura (LON:BELL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation. Does the MarketBeat Community favor RUA or BELL? RUA Life Sciences and Belluscura both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformRUA Life SciencesOutperform VotesNo VotesUnderperform Votes6100.00% BelluscuraN/AN/A Which has more risk and volatility, RUA or BELL? RUA Life Sciences has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. Comparatively, Belluscura has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500. Is RUA or BELL more profitable? Belluscura has a net margin of 0.00% compared to RUA Life Sciences' net margin of -65.72%. RUA Life Sciences' return on equity of -24.27% beat Belluscura's return on equity.Company Net Margins Return on Equity Return on Assets RUA Life Sciences-65.72% -24.27% -17.50% Belluscura N/A -85.01%-43.53% Does the media prefer RUA or BELL? In the previous week, RUA Life Sciences' average media sentiment score of 0.00 equaled Belluscura'saverage media sentiment score. Company Overall Sentiment RUA Life Sciences Neutral Belluscura Neutral Do insiders and institutionals hold more shares of RUA or BELL? 26.0% of RUA Life Sciences shares are held by institutional investors. Comparatively, 6.3% of Belluscura shares are held by institutional investors. 51.3% of RUA Life Sciences shares are held by insiders. Comparatively, 56.3% of Belluscura shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, RUA or BELL? RUA Life Sciences has higher revenue and earnings than Belluscura. RUA Life Sciences is trading at a lower price-to-earnings ratio than Belluscura, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRUA Life Sciences£2.19M2.98-£1.44M-£0.04-263.00Belluscura£1.80M8.98-£18.60M-£0.10-96.00 SummaryRUA Life Sciences beats Belluscura on 7 of the 11 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get RUA Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RUA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RUA vs. The Competition Export to ExcelMetricRUA Life SciencesMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£6.53M£2.25B£5.14B£1.90BDividend Yield1.44%2.37%5.09%5.55%P/E Ratio-263.00214.9990.051,821.81Price / Sales2.98200.841,117.09386,342.76Price / Cash2.4015.3843.1028.54Price / Book0.884.214.782.78Net Income-£1.44M£77.46M£120.31M£157.16M7 Day Performance-4.36%-0.34%-1.92%-2.00%1 Month Performance-8.52%9.75%13.65%21.23%1 Year Performance6.26%9.41%28.34%29.20% RUA Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RUARUA Life SciencesN/AGBX 10.52-4.4%N/A+6.3%£6.53M£2.19M-263.0048BELLBelluscuraN/AGBX 10flatN/A-56.4%£16.84M£1.80M-100.0024Gap UpPOLXPolarean ImagingN/AGBX 1.35flatN/A-79.9%£16.34M£1.87M-67.5028IHCInspiration Healthcare GroupN/AGBX 12.75-5.6%N/A-68.5%£11.43M£34.30M-91.07224High Trading VolumeAVOAdvanced OncotherapyN/AGBX 1.75-9.1%N/AN/A£9.50MN/A-25.003,900Gap DownMHCMyHealthCheckedN/AGBX 11.25flatN/A+8.4%£5.85M£9.39M-562.5016Gap DownSUNSurgical Innovations GroupN/AGBX 0.55flatN/A-24.1%£5.13M£12.54M-21.1180News CoverageDEMGDeltex Medical GroupN/AGBX 0.08flatN/A-52.0%£1.52M£1.78M-5.7537SNSmith & Nephew3.7082 of 5 starsGBX 995-0.3%GBX 3,956.20+297.6%-8.7%£8.68B£5.64B3,697.0418,452Insider TradeNews CoverageHigh Trading VolumeMXCTMaxCyteN/AGBX 340+1.8%N/A-12.8%£357.31M£45.44M-1,293.2780NIOXNIOX GroupN/AGBX 63.60flatN/A-2.8%£269.75M£39M3,180.0092Insider TradeNews CoverageGap Down Related Companies and Tools Related Companies BELL Competitors POLX Competitors IHC Competitors AVO Competitors MHC Competitors SUN Competitors DEMG Competitors SN Competitors MXCT Competitors NIOX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:RUA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RUA Life Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share RUA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
